Acadian Asset Management Cut Bio Rad Labs (BIO) Stake By $1.14 Million; 1 Analysts Bullish PDF Solutions, Inc. (PDFS)

Among 2 analysts covering PDF Solutions Inc (NASDAQ:PDFS), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. PDF Solutions Inc had 4 analyst reports since November 18, 2015 according to SRatingsIntel. The rating was maintained by DA Davidson on Thursday, October 13 with “Buy”. As per Tuesday, February 23, the company rating was initiated by Craig Hallum. The firm has “Hold” rating by Craig Hallum given on Friday, July 29. See PDF Solutions, Inc. (NASDAQ:PDFS) latest ratings:

Acadian Asset Management Llc decreased Bio Rad Labs Inc (BIO) stake by 0.67% reported in 2016Q4 SEC filing. Acadian Asset Management Llc sold 6,267 shares as Bio Rad Labs Inc (BIO)’s stock rose 14.54%. The Acadian Asset Management Llc holds 929,522 shares with $169.43 million value, down from 935,789 last quarter. Bio Rad Labs Inc now has $6.23 billion valuation. The stock rose 2.46% or $5.04 reaching $210.26. About 164,624 shares traded. Bio-Rad Laboratories, Inc. (NYSE:BIO) has risen 28.81% since September 12, 2016 and is uptrending. It has outperformed by 20.33% the S&P500.

Investors sentiment increased to 1.22 in Q4 2016. Its up 0.28, from 0.94 in 2016Q3. It is positive, as 6 investors sold PDF Solutions, Inc. shares while 35 reduced holdings. 16 funds opened positions while 34 raised stakes. 23.31 million shares or 2.82% more from 22.67 million shares in 2016Q3 were reported. Bnp Paribas Arbitrage Sa has invested 0% in PDF Solutions, Inc. (NASDAQ:PDFS). Fmr Lc holds 218,200 shares or 0% of its portfolio. Barclays Public Ltd Co has invested 0% in PDF Solutions, Inc. (NASDAQ:PDFS). Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% of its portfolio in PDF Solutions, Inc. (NASDAQ:PDFS). Goldman Sachs Grp accumulated 46,535 shares. Great West Life Assurance Can reported 2,624 shares. Brown Advisory accumulated 0% or 12,280 shares. Millrace Asset Gp Inc invested 1.85% in PDF Solutions, Inc. (NASDAQ:PDFS). California State Teachers Retirement, a California-based fund reported 55,780 shares. Blackrock Fund Advsrs holds 0% of its portfolio in PDF Solutions, Inc. (NASDAQ:PDFS) for 871,360 shares. Renaissance Technology Ltd Llc holds 0.01% or 318,900 shares in its portfolio. Palisade Mngmt Lc Nj holds 0.08% or 88,970 shares in its portfolio. Vanguard Grp Inc Inc reported 0% of its portfolio in PDF Solutions, Inc. (NASDAQ:PDFS). Peak6 Invs L P holds 1,764 shares. Cornerstone Cap Mngmt Lc stated it has 8,900 shares or 0% of all its holdings.

PDF Solutions, Inc. is a provider of infrastructure technologies and services for integrated circuits . The company has market cap of $704.16 million. The Company’s technologies and services focus on the IC manufacturing process life cycle. It has a 78.74 P/E ratio. It operates in the segment of licensing and implementation of yield improvement solutions for integrated circuit manufacturers.

About 40,022 shares traded. PDF Solutions, Inc. (NASDAQ:PDFS) has risen 35.32% since September 12, 2016 and is uptrending. It has outperformed by 26.84% the S&P500.

Since November 8, 2016, it had 0 insider purchases, and 3 insider sales for $393,147 activity. $123,646 worth of PDF Solutions, Inc. (NASDAQ:PDFS) was sold by WALKER GREGORY C on Tuesday, November 8. Kim KwangH sold $131,486 worth of stock or 6,000 shares.

Acadian Asset Management Llc increased Firstenergy Corp (NYSE:FE) stake by 19,151 shares to 19,661 valued at $609,000 in 2016Q4. It also upped Arcbest Corp (NASDAQ:ARCB) stake by 189,704 shares and now owns 314,513 shares. Walgreens Boots Alliance Inc was raised too.

Among 3 analysts covering Bio-Rad Laboratories (NYSE:BIO), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Bio-Rad Laboratories had 7 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Wednesday, April 12. The firm earned “Buy” rating on Thursday, October 13 by CL King. Jefferies maintained Bio-Rad Laboratories, Inc. (NYSE:BIO) on Wednesday, September 7 with “Buy” rating.

Analysts await Bio-Rad Laboratories, Inc. (NYSE:BIO) to report earnings on May, 4. They expect $0.27 earnings per share, down 35.71% or $0.15 from last year’s $0.42 per share. BIO’s profit will be $8.00 million for 194.69 P/E if the $0.27 EPS becomes a reality. After $1.25 actual earnings per share reported by Bio-Rad Laboratories, Inc. for the previous quarter, Wall Street now forecasts -78.40% negative EPS growth.

Investors sentiment increased to 1.17 in Q4 2016. Its up 0.09, from 1.08 in 2016Q3. It increased, as 25 investors sold BIO shares while 73 reduced holdings. 39 funds opened positions while 76 raised stakes. 18.93 million shares or 3.35% more from 18.31 million shares in 2016Q3 were reported. Louisiana State Employees Retirement System holds 0.05% or 5,100 shares. Highland Capital Mgmt LP invested 0.23% of its portfolio in Bio-Rad Laboratories, Inc. (NYSE:BIO). Jpmorgan Chase & has 650 shares for 0% of their portfolio. First Quadrant LP Ca accumulated 56,462 shares. Intrepid Capital Mngmt has invested 2.78% of its portfolio in Bio-Rad Laboratories, Inc. (NYSE:BIO). Nwq Investment Mgmt Co Lc owns 406,157 shares for 1.01% of their portfolio. Beaconlight Capital Limited Liability Corp stated it has 27,995 shares. Stewart & Patten Limited Liability accumulated 0.1% or 2,878 shares. Plante Moran Financial Ltd Co has invested 0% in Bio-Rad Laboratories, Inc. (NYSE:BIO). Nuveen Asset Management Ltd Co has invested 0% in Bio-Rad Laboratories, Inc. (NYSE:BIO). Morgan Stanley holds 839,988 shares or 0.05% of its portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) reported 725 shares. Sei accumulated 48,687 shares. Ubs Asset Mngmt Americas stated it has 0.1% of its portfolio in Bio-Rad Laboratories, Inc. (NYSE:BIO). Great Lakes Advisors Ltd Liability Corporation has 0.14% invested in Bio-Rad Laboratories, Inc. (NYSE:BIO) for 30,006 shares.